Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
- Resource Type
- Article
- Authors
- Wiegand, Ryan E.; Deng, Yangyang; Deng, Xiaoyi; Lee, Adam; Meyer, William A.; Letovsky, Stanley; Charles, Myrna D.; Gundlapalli, Adi V.; MacNeil, Adam; Hall, Aron J.; Thornburg, Natalie J.; Jones, Jefferson; Iachan, Ronaldo; Clarke, Kristie E.N.
- Source
- The Lancet Regional Health - Americas; February 2023, Vol. 18 Issue: 1
- Subject
- Language
- ISSN
- 2667193X
Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can reveal trends and differences in subgroups and capture undetected or unreported infections that are not included in case-based surveillance systems.